Announce Date | 05/13/2025 |
EPS Normalized Actual | $-0.06 (Beat by $0.15) |
EPS GAAP Actual | $-0.06 (Beat by $0.15) |
Revenue Actual | $0.020401B |
Revenue Surprise | Beat by $20.401M |
Announce Date | 07/01/2025 (Pre-Market) |
EPS Normalized Estimate | $-0.22 |
EPS GAAP Estimate | $-0.22 |
Revenue Estimate | $0.017118878B |
Fiscal Period Ending | EPS Estimate | Forward PE | Low | High | # of Analysts |
---|---|---|---|---|---|
Dec 2029 | 2.89667 | 3.36 | 2.41858 | 3.42777 | 3 |
Dec 2028 | 2.532 | 3.85 | 1.78016 | 3.8889 | 2 |
Period | EPS | Beat / Miss | Revenue | YoY | Beat / Miss |
---|---|---|---|---|---|
FQ1 2025 (Mar 2025) | -0.0573 | -0.0573 | 0.020401B | 83.21% | 20.4M |
FQ4 2024 (Dec 2024) | 1.51 | 1.51 | 0.012043B | -9.75% | 12.04M |
FQ3 2024 (Sep 2024) | -0.69 | -0.69 | 0.003695B | 21.65% | 3.7M |
FQ2 2024 (Jun 2024) | -0.48 | -0.48 | 0.004449B | 100% | 4.45M |
FQ1 2024 (Mar 2024) | -0.4 | -0.4 | 0.003425B | 100% | 3.43M |
FQ4 2023 (Dec 2023) | -0.4 | -0.4 | 0.013217B | 100% | 13.22M |
FQ4 2013 (Dec 2013) | -12.37 | -12.37 | 0B | NAN% | 0M |
FQ3 2023 (Sep 2023) | -0.4 | -0.4 | 0.002895B | 100% | 2.9M |
FQ4 Announce Date
07/01/2025 (Pre-Market)
Consensus EPS Estimates
-0.22
Consensus Revenue Estimates
0.017118878B
Fiscal Period Ending | EPS Estimate | YoY Growth(%) | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ4 2027 (Dec 2027) | 0 | -- | 0 | 0 | 3 |
FQ3 2027 (Sep 2027) | 0 | -- | 0 | 0 | 3 |
FQ2 2027 (Jun 2027) | 0 | -- | 0 | 0 | 3 |
FQ1 2027 (Mar 2027) | 0 | -- | 0 | 0 | 3 |
FQ4 2026 (Oct 2026) | 0 | -- | 0 | 0 | 1 |
FQ3 2026 (Jul 2026) | 0 | -- | 0 | 0 | 1 |
FQ2 2026 (Jun 2026) | 0 | -- | 0 | 0 | 1 |
FQ1 2026 (Mar 2026) | 0 | INF | 0 | 0 | 1 |
FQ4 2025 (Oct 2025) | -0.17 | 988.24 | -0.18844 | -0.14935 | 2 |
Fiscal Period Ending | Revenue Estimate | YoY Growth(%) | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ4 2027 (Dec 2027) | 0.08B | -- | 0.07B | 0.09B | 4 |
FQ3 2027 (Sep 2027) | 0.08B | -- | 0.06B | 0.09B | 4 |
FQ2 2027 (Jun 2027) | 0.07B | -- | 0.06B | 0.08B | 4 |
FQ1 2027 (Mar 2027) | 0.07B | -- | 0.06B | 0.08B | 4 |
FQ4 2026 (Oct 2026) | 0.03B | -- | 0.03B | 0.03B | 2 |
FQ3 2026 (Jul 2026) | 0.03B | -- | 0.02B | 0.03B | 2 |
FQ2 2026 (Jun 2026) | 0.03B | -- | 0.02B | 0.03B | 2 |
FQ1 2026 (Mar 2026) | 0.03B | 21.23 | 0.02B | 0.03B | 2 |
FQ4 2025 (Oct 2025) | 0.02B | 43.04 | 0.02B | 0.02B | 1 |
EPS # of Up Revisions
4
EPS # of Down Revisions
4
Revenue # of Up Revisions
6
Revenue # of Down Revisions
3
Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
EPS # of Beats
1
EPS # of Misses
7
EPS # of in-lines
0
Revenue # of Beats
7
Revenue # of Misses
0
Revenue # of in-lines
1
Earnings Date | EPS Estimate | EPS Actual | Surprise | Surprise % |
---|---|---|---|---|
FQ1 2025 (Mar 2025) | -0.0573 | -0.0573 | 100% | |
FQ4 2024 (Dec 2024) | 1.51 | 1.51 | 100% | |
FQ3 2024 (Sep 2024) | -0.69 | -0.69 | 100% | |
FQ2 2024 (Jun 2024) | -0.48 | -0.48 | 100% | |
FQ1 2024 (Mar 2024) | -0.4 | -0.4 | 100% | |
FQ4 2023 (Dec 2023) | -0.4 | -0.4 | 100% | |
FQ4 2013 (Dec 2013) | -12.37 | -12.37 | 100% | |
FQ3 2023 (Sep 2023) | -0.4 | -0.4 | 100% |
Earnings Date | Revenue Estimate | Revenue Actual | Surprise | Surprise % |
---|---|---|---|---|
FQ1 2025 (Mar 2025) | $0B | $0.02B | $20.4M | 100% |
FQ4 2024 (Dec 2024) | $0B | $0.01B | $12.04M | 100% |
FQ3 2024 (Sep 2024) | $0B | $0B | $3.7M | 100% |
FQ2 2024 (Jun 2024) | $0B | $0B | $4.45M | 100% |
FQ1 2024 (Mar 2024) | $0B | $0B | $3.43M | 100% |
FQ4 2023 (Dec 2023) | $0B | $0.01B | $13.22M | 100% |
FQ4 2013 (Dec 2013) | $0B | $0B | $0M | NAN% |
FQ3 2023 (Sep 2023) | $0B | $0B | $2.9M | 100% |